These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29439249)

  • 1. Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability.
    Liu J; Lin J; He S; Wu C; Wang B; Liu J; Duan Y; Liu T; Shan S; Yang K; Dong N; Ji Q; Huang K; Li D
    Cell Physiol Biochem; 2018; 45(3):1034-1050. PubMed ID: 29439249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
    Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice.
    Ji Q; Meng K; Yu K; Huang S; Huang Y; Min X; Zhong Y; Wu B; Liu Y; Nie S; Zhang J; Zhou Y; Zeng Q
    Sci Rep; 2017 Jun; 7(1):3310. PubMed ID: 28607385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1.
    Wang Y; Wang W; Xu H; Sun Y; Sun J; Jiang Y; Yao J; Tian Y
    Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Li B; Luo YR; Zhang Q; Fu SH; Chen YD; Tian JW; Guo Y
    Vascul Pharmacol; 2021 Oct; 140():106854. PubMed ID: 33781961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of small proline-rich repeat protein 3 as a novel atheroprotective factor that promotes adaptive Akt signaling in vascular smooth muscle cells.
    Segedy AK; Pyle AL; Li B; Zhang Y; Babaev VR; Jat P; Fazio S; Atkinson JB; Linton MF; Young PP
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2527-36. PubMed ID: 25278290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.
    Rattik S; Hultman K; Rauch U; Söderberg I; Sundius L; Ljungcrantz I; Hultgårdh-Nilsson A; Wigren M; Björkbacka H; Fredrikson GN; Nilsson J
    Atherosclerosis; 2015 Oct; 242(2):506-14. PubMed ID: 26298743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis.
    Beneit N; Martín-Ventura JL; Rubio-Longás C; Escribano Ó; García-Gómez G; Fernández S; Sesti G; Hribal ML; Egido J; Gómez-Hernández A; Benito M
    Cardiovasc Diabetol; 2018 Feb; 17(1):31. PubMed ID: 29463262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD137-inducing factors from T cells and macrophages accelerate the destabilization of atherosclerotic plaques in hyperlipidemic mice.
    Jung IH; Choi JH; Jin J; Jeong SJ; Jeon S; Lim C; Lee MR; Yoo JY; Sonn SK; Kim YH; Choi BK; Kwon BS; Seoh JY; Lee CW; Kim DY; Oh GT
    FASEB J; 2014 Nov; 28(11):4779-91. PubMed ID: 25059229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
    Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Sarcoglycan Deficiency Reduces Atherosclerotic Plaque Development in ApoE-Null Mice.
    Murugesan V; Degerman E; Holmen-Pålbrink AK; Duner P; Knutsson A; Hultgårdh-Nilsson A; Rauch U
    J Vasc Res; 2017; 54(4):235-245. PubMed ID: 28768281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DNA damage in smooth muscle cells in atherosclerosis.
    Gray K; Kumar S; Figg N; Harrison J; Baker L; Mercer J; Littlewood T; Bennett M
    Circ Res; 2015 Feb; 116(5):816-26. PubMed ID: 25524056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.